Loading...
Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
BACKGROUND: Adoptive transfer of T cells genetically engineered with a chimeric antigen receptor (CAR) has successfully been used to treat both chronic and acute lymphocytic leukemia as well as other hematological cancers. Experimental therapy with CAR-engineered T cells has also shown promising res...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3899402/ https://ncbi.nlm.nih.gov/pubmed/24438073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-30 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|